Citigroup Inc Intra Cellular Therapies, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Citigroup Inc holds 15,569 shares of ITCI stock, worth $1.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,569

Previous 18,993 18.03%

Holding current value

$1.98 Million

Previous $1.3 Million 12.46%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$67.99 - $80.84 $232,797 - $276,796	-3,424 Reduced 18.03%	15,569 $1.14 Million
Q2 2024 Aug 12, 2024	SELL	$64.76 - $79.84 $510,049 - $628,819	-7,876 Reduced 29.31%	18,993 $1.3 Million
Q1 2024 May 10, 2024	SELL	$64.37 - $75.65 $791,493 - $930,192	-12,296 Reduced 31.4%	26,869 $1.86 Million
Q4 2023 Feb 09, 2024	BUY	$46.37 - $73.65 $1.35 Million - $2.14 Million	29,120 Added 289.9%	39,165 $2.8 Million
Q3 2023 Nov 09, 2023	SELL	$52.09 - $64.1 $1.42 Million - $1.75 Million	-27,305 Reduced 73.11%	10,045 $523,000
Q2 2023 Aug 10, 2023	BUY	$54.67 - $66.44 $1.41 Million - $1.72 Million	25,832 Added 224.28%	37,350 $2.37 Million
Q1 2023 May 11, 2023	BUY	$43.8 - $56.99 $105,820 - $137,687	2,416 Added 26.54%	11,518 $623,000
Q4 2022 Feb 09, 2023	SELL	$44.07 - $54.45 $72,274 - $89,298	-1,640 Reduced 15.27%	9,102 $481,000
Q3 2022 Nov 10, 2022	SELL	$42.7 - $59.99 $265,124 - $372,477	-6,209 Reduced 36.63%	10,742 $499,000
Q2 2022 Aug 10, 2022	BUY	$43.0 - $65.64 $47,773 - $72,926	1,111 Added 7.01%	16,951 $968,000
Q1 2022 May 12, 2022	SELL	$38.74 - $62.09 $303,566 - $486,537	-7,836 Reduced 33.1%	15,840 $969,000
Q4 2021 Feb 10, 2022	SELL	$35.2 - $53.42 $1.53 Million - $2.32 Million	-43,471 Reduced 64.74%	23,676 $1.24 Million
Q3 2021 Nov 10, 2021	BUY	$28.72 - $42.49 $1.93 Million - $2.85 Million	67,147 New	67,147 $2.5 Million

Others Institutions Holding ITCI

# of Institutions

384

Shares Held

84.9M

Call Options Held

319K

Put Options Held

143K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account